Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR201705002282393
PACTR201705002282393
Not yet recruiting
未知

The role of epigenetic modifications in autism spectrum disorder through DNA methylation

the Vice Dean Research Office.0 sites40 target enrollmentMay 10, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
the Vice Dean Research Office.
Enrollment
40
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 10, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
the Vice Dean Research Office.

Eligibility Criteria

Inclusion Criteria

  • •a. All enrolled children with ASD will be:
  • •1\-Exhibit symptoms within the typical triad of autistic traits: communication impairment, social deficits, and ritualistic interests.
  • •2\-2\-6 years old.
  • •3\-Drug\-naïve.

Exclusion Criteria

  • •The control subjects will also clinically examined by the psychiatrist to exclude any sub\-clinical autistic features. Children with ASD and controls will excluded from the study if
  • •2\-They receive treatment for any reason.
  • •3\-\-Endocrinological disease, mental retardation, communication disorder, psychotic disorder, attention deficit hyperactivity disorder and learning disorders seen in the children or their family members.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
The Role of Epigenetic Modifications in Autism Spectrum DisorderAutism Spectrum Disorder
NCT03152838Assiut University40
Recruiting
Not Applicable
eural and molecular risk mechanisms of autism, affective disorders and psychoses.F20F31F33F84SchizophreniaBipolar affective disorderRecurrent depressive disorderPervasive developmental disorders
DRKS00008176Zentralinstitut für seelische Gesundheit500
Not yet recruiting
Not Applicable
EGAL: Environmental and Genetic Effects on Autism Longitudinal
NL-OMON51612Vrije Universiteit1,000
Completed
Not Applicable
Effect to other mental diseases in the autism spectrum disorder communication programpsychiatric disorder except autistic spectrum disorder
JPRN-UMIN000033512kochi medical school
Completed
Not Applicable
Exosomal MicroRNA Expression in Children With Autism Spectrum DisorderAutism Spectrum Disorder
NCT01749670State University of New York - Upstate Medical University45